Alan Tan, MD, discusses factors influencing the choice of immunotherapy plus tyrosine kinase inhibitor vs dual IO in patients ...
The LEAP-015 study is evaluating Merck's Keytruda and Eisai's Lenvima plus chemotherapy in certain types of gastroesophageal ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback